Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents

Andrographolide (AGP), a naturally occurring bioactive compound, has been investigated as a lead compound in cancer drug development. Its multidimensional therapeutic effects have raised interest among medicinal chemists, which has led to extensive structural modification of the compound, resulting...

Full description

Bibliographic Details
Main Authors: Soo, Hon Liong, Quah, Shun Ying, Sulaiman, Ibrahim, Sagineedu, Sreenivasa Rao, Lim, Chee Woei, Stanslas, Johnson
Format: Article
Language:English
Published: Elsevier 2019
Online Access:http://psasir.upm.edu.my/id/eprint/80553/1/ANDRO.pdf
_version_ 1825951315961839616
author Soo, Hon Liong
Quah, Shun Ying
Sulaiman, Ibrahim
Sagineedu, Sreenivasa Rao
Lim, Chee Woei
Stanslas, Johnson
author_facet Soo, Hon Liong
Quah, Shun Ying
Sulaiman, Ibrahim
Sagineedu, Sreenivasa Rao
Lim, Chee Woei
Stanslas, Johnson
author_sort Soo, Hon Liong
collection UPM
description Andrographolide (AGP), a naturally occurring bioactive compound, has been investigated as a lead compound in cancer drug development. Its multidimensional therapeutic effects have raised interest among medicinal chemists, which has led to extensive structural modification of the compound, resulting in analogues with improved pharmacological and pharmaceutical properties. Nevertheless, the analogues with the improved properties need to be rigorously studied to identify drug-like lead compounds. We scrutinised articles published from 2012 to 2018, to objectively provide opinions on the mechanisms of action of AGP and its analogues, as well as their potential as viable anticancer drugs. Preclinical and clinical data, along with the extensive medicinal chemistry efforts, indicate the compounds are potential anticancer agents with specific value in treating recalcitrant cancers such as pancreatic and lung cancers.
first_indexed 2024-03-06T10:28:10Z
format Article
id upm.eprints-80553
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T10:28:10Z
publishDate 2019
publisher Elsevier
record_format dspace
spelling upm.eprints-805532021-04-27T03:14:14Z http://psasir.upm.edu.my/id/eprint/80553/ Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents Soo, Hon Liong Quah, Shun Ying Sulaiman, Ibrahim Sagineedu, Sreenivasa Rao Lim, Chee Woei Stanslas, Johnson Andrographolide (AGP), a naturally occurring bioactive compound, has been investigated as a lead compound in cancer drug development. Its multidimensional therapeutic effects have raised interest among medicinal chemists, which has led to extensive structural modification of the compound, resulting in analogues with improved pharmacological and pharmaceutical properties. Nevertheless, the analogues with the improved properties need to be rigorously studied to identify drug-like lead compounds. We scrutinised articles published from 2012 to 2018, to objectively provide opinions on the mechanisms of action of AGP and its analogues, as well as their potential as viable anticancer drugs. Preclinical and clinical data, along with the extensive medicinal chemistry efforts, indicate the compounds are potential anticancer agents with specific value in treating recalcitrant cancers such as pancreatic and lung cancers. Elsevier 2019-09 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/80553/1/ANDRO.pdf Soo, Hon Liong and Quah, Shun Ying and Sulaiman, Ibrahim and Sagineedu, Sreenivasa Rao and Lim, Chee Woei and Stanslas, Johnson (2019) Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents. Drug Discovery Today, 24 (9). pp. 1890-1898. ISSN 1359-6446; ESSN: 1878-5832 https://www.sciencedirect.com/science/article/pii/S1359644618302216 10.1016/j.drudis.2019.05.017
spellingShingle Soo, Hon Liong
Quah, Shun Ying
Sulaiman, Ibrahim
Sagineedu, Sreenivasa Rao
Lim, Chee Woei
Stanslas, Johnson
Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents
title Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents
title_full Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents
title_fullStr Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents
title_full_unstemmed Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents
title_short Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents
title_sort advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents
url http://psasir.upm.edu.my/id/eprint/80553/1/ANDRO.pdf
work_keys_str_mv AT soohonliong advancesandchallengesindevelopingandrographolideanditsanaloguesascancertherapeuticagents
AT quahshunying advancesandchallengesindevelopingandrographolideanditsanaloguesascancertherapeuticagents
AT sulaimanibrahim advancesandchallengesindevelopingandrographolideanditsanaloguesascancertherapeuticagents
AT sagineedusreenivasarao advancesandchallengesindevelopingandrographolideanditsanaloguesascancertherapeuticagents
AT limcheewoei advancesandchallengesindevelopingandrographolideanditsanaloguesascancertherapeuticagents
AT stanslasjohnson advancesandchallengesindevelopingandrographolideanditsanaloguesascancertherapeuticagents